ScoreWhy is Fusion Antibodies Plc ?
1
Flat results in Sep 25
- INTEREST(HY) At GBP 0.01 MM has Grown at 400%
- ROCE(HY) Lowest at -164.37%
- DEBT-EQUITY RATIO (HY) Highest at 18.73 %
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -36.00%, its profits have risen by 9.8%
3
Underperformed the market in the last 1 year
- Even though the market (FTSE 100) has generated returns of 16.06% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -36.00% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Fusion Antibodies Plc for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Fusion Antibodies Plc
-36.0%
3.44
68.18%
FTSE 100
16.06%
1.36
11.82%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-16.95%
EBIT Growth (5y)
-28.23%
EBIT to Interest (avg)
-2.01
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
1.42
Tax Ratio
4.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
14.38
EV to EBIT
-7.51
EV to EBITDA
-7.96
EV to Capital Employed
14.23
EV to Sales
8.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-189.50%
ROE (Latest)
-146.70%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Fusion Antibodies Plc
Pre-Tax Profit
Highest at GBP -0.55 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (GBP MM)
Net Profit
Highest at GBP -0.51 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (GBP MM)
EPS
Highest at GBP -0
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (GBP)
Inventory Turnover Ratio
Highest at 5.38 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -153.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Fusion Antibodies Plc
Interest
At GBP 0.01 MM has Grown at 400%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (GBP MM)
Debt-Equity Ratio
Highest at 18.73 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
